Madryn Health Partners

TMS NeuroHealth Centers Tysons Corner, LLC owns and operates healthcare centers providing repetitive transcranial magnetic stimulation therapy (TMS) for the treatment of major depressive disorder (MDD) and other neurological diseases. TMS NeuroHealth Centers Tysons Corner, LLC was incorporated in 2011 and is based in McLean, Virginia.

Calibrate Health, Inc. is a telemedicine startup that specializes in weight loss services through a comprehensive metabolic health approach. Founded in 2019 and based in New York, the company offers a one-year metabolic reset program grounded in contemporary weight health science. This program, which is endorsed by a clinical advisory board, combines personalized medication with individualized coaching, addressing the underlying causes of weight issues. By focusing on the unique biology, goals, and lifestyles of its clients, Calibrate aims to achieve sustainable weight loss of at least 10%.

Bigfoot Biomedical, Inc., a health solution company, develops automated insulin delivery systems for people with Type 1 Diabetes (T1D). It develops a T1D Management System with cloud connectivity and human-centered-automation; and insulin pumps. Bigfoot Biomedical, Inc. was formerly known as SmartLoop Labs, Inc. and changed its name to in Bigfoot Biomedical, Inc. February 2015. The company was incorporated in 2014 and is based in Milpitas, California.

SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative medicines to meet unmet medical needs both in the United States and internationally. The company offers several marketed products, including Sympazan, an oral soluble film for treating Lennox-Gastaut syndrome; Suboxone, a sublingual film for opioid dependence; and Zuplenz, an oral soluble film for nausea and vomiting related to chemotherapy and post-operative recovery. Additionally, Aquestive's proprietary product candidates include Libervant, a buccal film for epileptic seizures, and Exservan, an oral film for Amyotrophic Lateral Sclerosis. The company's pipeline also features AQST-108, a sublingual film for anaphylaxis, AQST-305 for acromegaly, and APL-130277 for Parkinson's disease. Established in 2004 and headquartered in Warren, New Jersey, Aquestive Therapeutics leverages its proprietary technologies to address complex healthcare challenges and partners with other pharmaceutical companies to enhance drug delivery methods.

Veran Medical Technologies is an image-guided medical device company that helps physicians diagnose disease and deliver therapies. It develops a suite of products to enable physicians to diagnose disease and deliver therapies. It offers standards for minimally invasive delivery of interventional oncology therapies. The company provides plug-n-play delivery systems and navigated instruments. Its IG4 Platform allows clinicians to visualize various types of information integrated with a CT dataset, such as respiration, contrast-enhanced structures, PET, and ultrasound. The company also provides SPiN Drive System that acts as a GPS-like system to enable pulmonologists and surgeons to access peripheral solitary pulmonary nodules to diagnose malignancy. The company was incorporated in 2007 and is headquartered in St. Louis, Missouri.

SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.

Establishment Labs is a medical technology company headquartered in Alajuela, Costa Rica, specializing in the design, development, manufacturing, and marketing of silicone-filled breast and body shaping implants, primarily under the Motiva Implants brand. The company offers a diverse range of breast implants with various options for surface, shape, size, base, and projection. In addition to implants, Establishment Labs provides advanced solutions such as the Divina 3D surgical simulation system for pre-surgical consultations and the Puregraft technology for autologous fat harvesting and redistribution. The company operates globally, selling its products through exclusive distributors and a direct sales force in over 80 countries, while maintaining compliance with both FDA and ISO standards. Establishment Labs emphasizes innovation and quality assurance throughout its manufacturing processes, ensuring that its products meet the highest safety and performance standards.

BioQ Pharma is a specialty pharmaceutical company focused on developing and commercializing a range of ready-to-use infusible pharmaceuticals designed for post-surgical pain management, anesthesia, and sedation. Its product portfolio includes Ropivacaine for pain relief and Propofol for anesthesia, along with pipeline candidates in antibiotics and oncology. The company utilizes a proprietary unit-dose infusion system that enhances safety and efficiency at the point of care, addressing key issues such as medication errors and sterility. BioQ Pharma partners with several organizations, including Novartis' Sandoz unit and Cipla, to market its products across the U.S., European, and Asian markets. Established in 2003 and headquartered in San Francisco, California, BioQ Pharma also has operations in Gent, Belgium. The company was previously known as BioQuiddity Incorporated until its rebranding in 2015.

BioQ Pharma is a specialty pharmaceutical company focused on developing and commercializing a range of ready-to-use infusible pharmaceuticals designed for post-surgical pain management, anesthesia, and sedation. Its product portfolio includes Ropivacaine for pain relief and Propofol for anesthesia, along with pipeline candidates in antibiotics and oncology. The company utilizes a proprietary unit-dose infusion system that enhances safety and efficiency at the point of care, addressing key issues such as medication errors and sterility. BioQ Pharma partners with several organizations, including Novartis' Sandoz unit and Cipla, to market its products across the U.S., European, and Asian markets. Established in 2003 and headquartered in San Francisco, California, BioQ Pharma also has operations in Gent, Belgium. The company was previously known as BioQuiddity Incorporated until its rebranding in 2015.

Venus Concept Inc. is a medical aesthetic technology company based in Toronto, Canada, specializing in innovative solutions for aesthetic treatments. Founded in 2009, the company offers a diverse range of products, including Venus Versa, a multi-treatment platform for non-surgical procedures; Venus Legacy, designed for skin tightening and body contouring; and Venus Viva, a customizable skin resurfacing device. Additionally, Venus Concept provides Venus Freeze Plus for anti-aging and non-invasive skin tightening, and Venus Bliss for fat reduction. The company also features advanced hair restoration technologies, including NeoGraft and ARTAS robotic systems, which streamline the follicle harvesting process. Committed to ethical practices and technological advancement, Venus Concept aims to enhance the patient experience in the medical aesthetics industry.